Evaluation of the Effects of Chinese Medical Treatment on Leucopenia After Chemotherapy in Breast Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hwei-Chung Wang, MD.
Devision of Breast Surgery, China Medical University Hospital
Principal Investigator - Yi-Chang Su, MD., PhD.
School of Chinese Medicine, China Medical University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Devision of Breast Surgery, China Medical University Hospital
Taichung, Taiwan, Taiwan
Recruiting - Devision of Breast Surgery, China Medical University Hospital
Taichung, Taiwan, Taiwan
Enrolling, by, invitation - Division of General Surgery, Tri-Service General Hospital
Taipei, Taiwan, Taiwan
Enrolling, by, invitation
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2011
- Primary completion
- 31 Dec 2012
- Completion
- 31 Dec 2012
- Last update posted
- 23 Oct 2012
- Registered enrollment
- 100
- Registry id
- NCT01359501
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.